<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="172033">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00856726</url>
  </required_header>
  <id_info>
    <org_study_id>20080669</org_study_id>
    <secondary_id>K23DK081673</secondary_id>
    <nct_id>NCT00856726</nct_id>
  </id_info>
  <brief_title>Racial Differences in Phosphorus Metabolism</brief_title>
  <official_title>Racial Differences in Phosphorus Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to study potential racial differences in renal phosphorus handling by
      provocatively testing urinary phosphorus excretion using parathyroid hormone infusions in
      healthy white volunteers compared to healthy black volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary phosphorus excretion</measure>
    <time_frame>six hours</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Healthy Volunteers</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1-34 parathyroid infusion</intervention_name>
    <description>1-34 parathyroid infusion at 0.055 mcg/kg/hr for 6 hours</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  Body mass index (BMI) within 20% ideal for their age and gender

        Exclusion Criteria:

          -  Abnormal urinalysis

          -  Pregnancy or breast-feeding

          -  Medical conditions impacting phosphorus metabolism—primary hyperparathyroidism;
             diabetes mellitus; gastrointestinal malabsorption disorders; hyper- or hypothyroidism

          -  Medications known to affect phosphorus metabolism— current use of phosphorus
             supplements, phosphorus binders, calcitriol or calcitriol analogues, regular antacid
             or laxative use, calcitonin, etidronate, anticonvulsants

          -  Hyper- or hypophosphatemia (≥ 4.6 mg/dl or ≤ 2.5 mg/dl respectively), hyper- or
             hypocalcemia (≥ 10.6 or ≤ 8.5 mg/dl respectively), or severe anemia (Hgb &lt; 8 g/dl for
             women and &lt; 9 g/dl for men)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orlando M Gutierrez, MD, MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <lastchanged_date>June 30, 2011</lastchanged_date>
  <firstreceived_date>March 4, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Orlando M. Gutierrez, MD, MMSc</name_title>
    <organization>University of Miami</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
